Peregrine Ventures

Peregrine Ventures

Peregrine was founded to invest in life science companies globally, with roots in Israel's medical innovation ecosystem. Eyal Lifschitz and Boaz Lifschitz co-founded the firm after launching and managing five startups of their own, an operational background that shapes Peregrine's emphasis on active portfolio support in business strategy, regulatory navigation, and team recruitment. The firm's strategy spans the entire corporate lifecycle. Its dedicated vehicles cover pre-seed incubation through the Incentive Incubator, early- and mid-stage venture funds, and Peregrine Growth, which targets mature companies in their final financing rounds before M&A or IPO. The portfolio concentrates on medical devices, pharmaceuticals and biotech, and digital health, with confirmed positions in over 70 companies including Aleph Farms, CartiHeal, Insightec, and Variantyx. Peregrine invests from Israel into North America and the broader Middle East and Central Asia region, sourcing across both early-stage startups and pre-IPO rounds. Peregrine lists Eyal Lifschitz and Boaz Lifschitz as co-founders and managing general partners, with Lior Shahory serving as general partner. Elazer Edelman chairs the medical advisory board. The firm is headquartered in Or Yehuda, Israel. In recent periods, Peregrine has continued investing out of its existing fund structures across devices, pharma, and digital health, though no specific fund close or team expansion event from the last 24 months is publicly documented. The firm's structural differentiator is its integrated continuum of investment vehicles under one roof — covering incubation, venture, and growth capital — which is uncommon among Israeli healthcare investors. This architecture lets Peregrine support a company from formation through exit without requiring entrepreneurs to re-educate new investors at each stage.